Ignite Creation Date:
2025-12-24 @ 12:44 PM
Ignite Modification Date:
2026-04-22 @ 3:14 PM
Study NCT ID:
NCT04802161
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-19
First Post:
2021-03-16
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-24
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-04-25
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-16
First Submit QC Date:
None
Study First Post Date:
2021-03-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-11-21
Results First Submit QC Date:
None
Results First Post Date:
2025-12-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-09
Last Update Post Date:
2025-12-19
Last Update Post Date Type:
ESTIMATED